MDUFMA technical corrections
This article was originally published in The Gray Sheet
Executive Summary
Final House vote on technical corrections to the Medical Device User Fee & Modernization Act is expected the week of March 8, according to Energy & Commerce staffers. The full committee unanimously approved Rep. Jim Greenwood's (R- Penn.) amended bill March 3, allowing for minor language modifications made in conference. Senate passage is expected to follow soon after, with Presidential endorsement possible by early April. The third-party inspection program is contingent upon the bill's passage (1"The Gray Sheet" Feb. 2, 2004, p. 8)...
You may also be interested in...
Third Party Inspections Await Reconciliation of Technical Corrections Bills
Third-party inspection proponents are hoping that momentum from House passage of the Medical Device User Fee & Modernization Act technical corrections bill will propel enactment within the next few weeks
US Q1 Consumer Health Earnings Preview: Label This One Historic And Challenging But Promising
US OTC drug and supplement firms’ reports of results for the first three months of 2024 began on April 19 with P&G. JP Morgan analysts say while “some retailers in the US in particular” are reducing consumer health inventories, for the overall sector they expect “a healthier balance of positive volume and lower pricing contribution.”
Keeping Track: Cancer Approvals From Lumisight Imaging To Adjuvant Alecensa
The US FDA’s approval of Lumicell’s optical imaging agent Lumisight makes a dozen novel approvals in 2024 for the Center for Drug Evaluation and Research.